A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as ...

The tumor microenvironment modulation market is poised for growth driven by increasing focus on advanced immunotherapies, tumor biology understanding, and combination cancer treatments. Expansion is ...

Small numbers of high-end German-designed SUVs are being assembled at a plant in Kaliningrad despite BMW pulling out of ...

An excellent debut, the Motorola Razr Fold is a well-rounded foldable phone that even lets you do big-screen activities on a ...

The concept of trained immunity has redefined innate immune responses as adaptable, durable, and context dependent. Natural killer (NK) cells, traditionally ...

Adults with blood cancers who receive stem cell transplants from matched donors now have a new defense against one of the ...

UCLA researchers have developed an engineered CAR T cell therapy that released immune-stimulating cytokines to strengthen anti-tumour activity against aggressive brain tumours in mouse ...

Volkswagen is planning to offer Apple Wallet car keys in future vehicles, according to new server-side Apple code. The code ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...